长春海伯尔生物技术有限责任公司是中国和古巴合资共建集研发、生产和销售为一体的生物制药企业。公司坐落在长春新区空港经济开发区,注册资金3.8亿元,占地面积约40公顷。目前公司已上市产品为重组人干扰素α2b注射液,该产品属广谱抗病毒治疗用生物制品,重组人干扰素α2b注射液是中国*上市的高规格干扰素产品,填补国内生物制药领域此项空白。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows